首頁 > 市場調查報告書 > 製藥

消化器

市場調查報告書

商品編碼

1671834

大腸激躁症治療市場按類型、適應症、藥物類別、給藥途徑、通路和地區分類

Irritable Bowel Syndrome Treatment Market, By Type, By Indication, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2025年02月26日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球大腸激躁症治療市場規模估計為 40.4 億美元，預計到 2032 年將達到 74.3 億美元，2025 年至 2032 年的複合年成長率為 9.1%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	40.4億美元
效能資料	從 2020 年到 2024 年	預測期	2025 至 2032 年
預測期：2025-2032年複合年成長率：	9.10%	2032 年價值預測	74.3億美元

數字。 2025 年大腸激躁症治療市場佔有率（按地區分類）

大腸激躁症(IBS) 是一種影響大腸的常見功能性胃腸道疾病。腸躁症 (IBS) 會導致腹部痙攣、腹脹、脹氣、腹瀉和便秘。美國國家醫學圖書館估計，到 2024 年 6 月，IBS 將影響全球約 11% 的人。腸躁症（IBS）的具體病因尚不清楚，但人們認為是由於消化道處理壓力和調節正常功能和感覺的方式發生變化所致。由於腸躁症（IBS）盛行率不斷上升以及對有效治療方案的需求不斷增加，全球大腸激躁症治療市場在過去幾年中一直保持穩定成長。

市場動態：

老年人口的不斷增加推動了全球大腸激躁症治療市場的發展，因為老年人更容易患上腸躁症。根據聯合國的數據，到 2050 年，全球 60 歲及以上人口數量將從 2017 年的 9.62 億增加到 21 億。此外，對 IBS 的認知不斷提高和診斷水平不斷提高也支持了該市場的成長。然而，缺乏核准用於治療 IBS 的藥物、開發新療法的成本高昂以及現有藥物的副作用阻礙因素了市場的成長。新型藥物配方和非藥物替代品的開發可能為市場提供有利可圖的機會。

本研究的主要特點

本報告對全球大腸激躁症治療市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。

它還揭示了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球大腸激躁症治療市場的主要企業根據公司亮點、產品系列、關鍵亮點、績效和策略等參數進行分析。

研究中介紹的主要企業包括 Ironwood Pharmaceuticals, Inc.、AbbVie Inc.、Astellas Pharma, Inc.、工業 Company Limited、AstraZeneca Plc.、Sebela Pharmaceuticals, Inc.、Bausch Health Companies Inc.、Theriva Biologics, Inc.、Aroot, Inc. exicon Pharmaceuticals, Inc.、GSK plc 和 Johnson & Johnson Services, Inc.

本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、高階市場策略、市場擴張和行銷策略做出明智的決策。

全球大腸激躁症治療市場報告涉及該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。

Ironwood Pharmaceuticals, Inc.
AbbVie Inc.
Astellas Pharma, Inc.
Takeda Pharmaceutical Company Limited
AstraZeneca Plc.
Sebela Pharmaceuticals, Inc.
Bausch Health Companies Inc.
Theriva Biologics, Inc.
Ardelyx, Inc.
Salix Pharmaceuticals, Inc.
Mallinckrodt Pharmaceuticals
Abbott Laboratories
Lexicon Pharmaceuticals, Inc.
GSK plc
Johnson & Johnson Services, Inc.

第 11 章分析師建議

命運之輪
分析師觀點
一致的機會圖

第 12 章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI506

Global Irritable Bowel Syndrome Treatment Market is estimated to be valued at US$ 4.04 Bn in 2025 and is expected to reach US$ 7.43 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	US$ 4.04 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.10%	2032 Value Projection:	US$ 7.43 Bn

Figure. Irritable Bowel Syndrome Treatment Market Share (%), By Region 2025

Irritable Bowel Syndrome Treatment Market - IMG1

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that affects the large intestine. IBS causes abdominal cramping, bloating, gas, and diarrhea and/or constipation. As per National Library of Medicine estimates, in June 2024, IBS affects around 11% of people worldwide. The exact causes of IBS are unknown, but it is believed to be due to changes in the way the gastrointestinal tract handles stress and regulates normal function and sensations. The global irritable bowel syndrome treatment market has been witnessing steady growth over the past few years owing to the increasing prevalence of IBS and growing demand for effective treatment options.

Market Dynamics:

The global irritable bowel syndrome treatment market is driven by the rising geriatric population, as seniors are more prone to develop IBS. According to the United Nations, the number of people aged 60 or above will increase from 962 million globally in 2017 to 2.1 billion in 2050. Moreover, growing awareness and better diagnosis of IBS are also supporting the growth of this market. However, the lack of approved drugs for IBS, high development costs of new therapies, and side effects associated with existing drugs are some of the key factors are hampering the market growth. The development of novel drug formulations and non-drug treatment alternatives can present lucrative opportunities in the market.

Key Features of the Study:

This report provides in-depth analysis of the global irritable bowel syndrome treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global irritable bowel syndrome treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Ironwood Pharmaceuticals, Inc., AbbVie Inc., Astellas Pharma, Inc., Takeda Pharmaceutical Company Limited, AstraZeneca Plc., Sebela Pharmaceuticals, Inc., Bausch Health Companies Inc., Theriva Biologics, Inc., Ardelyx, Inc., Salix Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Abbott Laboratories, Lexicon Pharmaceuticals, Inc., GSK plc, and Johnson & Johnson Services, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global irritable bowel syndrome treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Market Segmentation

By Type Insights (Revenue, USD Bn, 2020 - 2032)
- Irritable Bowel Syndrome with Constipation (IBS-C)
- Irritable Bowel Syndrome with Diarrhea (IBS-D)
- Mixed Irritable Bowel Syndrome (IBS-M)
By Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Abdominal Pain
- Bloating
- Constipation and Diarrhea
- Altered Bowel Habits
- Others
By Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
- Antispasmodics
- Laxatives
- Antidiarrheal Medications
- 5-HT3 Receptor Antagonists
- Guanylate Cyclase-C Agonists
- Anticholinergic
- Probiotics
- Antidepressants
- Antibiotics
- Dietary Supplements
- Others
By Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Rectal
- Parenteral
By Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Ironwood Pharmaceuticals, Inc.
- AbbVie Inc.
- Astellas Pharma, Inc.
- Takeda Pharmaceutical Company Limited
- AstraZeneca Plc.
- Sebela Pharmaceuticals, Inc.
- Bausch Health Companies Inc.
- Theriva Biologics, Inc.
- Ardelyx, Inc.
- Salix Pharmaceuticals, Inc.
- Mallinckrodt Pharmaceuticals
- Abbott Laboratories
- Lexicon Pharmaceuticals, Inc.
- GSK plc
- Johnson & Johnson Services, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Irritable Bowel Syndrome Treatment Market, By Type
- Global Irritable Bowel Syndrome Treatment Market, By Indication
- Global Irritable Bowel Syndrome Treatment Market, By Drug Class
- Global Irritable Bowel Syndrome Treatment Market, By Route of Administration
- Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel
- Global Irritable Bowel Syndrome Treatment Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Irritable Bowel Syndrome Treatment Market, By Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Irritable Bowel Syndrome with Constipation (IBS-C)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Irritable Bowel Syndrome with Diarrhea (IBS-D)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Mixed Irritable Bowel Syndrome (IBS-M)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Irritable Bowel Syndrome Treatment Market, By Indication, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Abdominal Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Bloating
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Constipation and Diarrhea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Altered Bowel Habits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Irritable Bowel Syndrome Treatment Market, By Drug Class, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Antispasmodics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Laxatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antidiarrheal Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5-HT3 Receptor Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Guanylate Cyclase-C Agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Anticholinergic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Probiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Dietary Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Irritable Bowel Syndrome Treatment Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Rectal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Irritable Bowel Syndrome Treatment Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Ironwood Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Astellas Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca Plc.
Sebela Pharmaceuticals, Inc.
Bausch Health Companies Inc.
Theriva Biologics, Inc.
Ardelyx, Inc.
Salix Pharmaceuticals, Inc.
Mallinckrodt Pharmaceuticals
Abbott Laboratories
Lexicon Pharmaceuticals, Inc.
GSK plc
Johnson & Johnson Services, Inc.